Literature DB >> 10535748

Increased toxicity of cocaine on human hepatocytes induced by ethanol: role of GSH.

X Ponsoda1, R Bort, R Jover, M J Gómez-Lechón, J V Castell.   

Abstract

Increased toxicity of cocaine to human hepatocytes is observed when cells are simultaneously incubated with ethanol. Ethanol might exacerbate cocaine hepatocyte toxicity by three different pathways: a) by increasing the oxidative metabolism of cocaine and hence the oxidative damage; b) by the formation of a more toxic metabolite, namely cocaethylene; or c) by decreasing the defence mechanisms of the cell (i.e. GSH). In the present study, experiments were conducted to investigate the feasibility of these hypotheses. In hepatocytes preincubated for 48 hr with ethanol, neither significant changes in cocaine metabolism nor cytotoxicity were found despite differences in hepatocyte p-nitrophenol hydroxylase (largely CYP2E1 activity). Cocaethylene, the transesterification product of cocaine and ethanol, was found to be more toxic than cocaine for human hepatocytes (3x). However, the small amount formed when human hepatocytes were incubated with cocaine and ethanol would hardly explain the increased toxicity observed. On the other hand, the simultaneous presence of cocaine and ethanol caused a sustained decline in the intracellular GSH content that was larger than that observed in cocaine- or ethanol-treated cultures. Parallel to this phenomenon, a significant increase in lipid peroxidation was observed, as compared to cells treated with equimolar amounts of cocaine, ethanol, or cocaethylene. Finally, depletion of hepatocyte GSH with diethylmaleate down to levels similar to those found in ethanol-treated cells made hepatocytes more susceptible to cocaine. Taken together, the results of this research suggest that by decreasing GSH levels, ethanol makes human hepatocytes more sensitive to cocaine-induced oxidative damage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535748     DOI: 10.1016/s0006-2952(99)00249-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Mitochondrial involvement in cocaine-treated rat hepatocytes: effect of N-acetylcysteine and deferoxamine.

Authors:  A Zaragoza; C Díez-Fernández; A M Alvarez; D Andrés; M Cascales
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

2.  CYP2E1-dependent hepatotoxicity and oxidative damage after ethanol administration in human primary hepatocytes.

Authors:  Lie-Gang Liu; Hong Yan; Ping Yao; Wen Zhang; Li-Jun Zou; Fang-Fang Song; Ke Li; Xiu-Fa Sun
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

3.  Cocaethylene, simultaneous alcohol and cocaine use, and liver fibrosis in people living with and without HIV.

Authors:  Javier A Tamargo; Kenneth E Sherman; Rafick-Pierre Sékaly; Rebeka Bordi; Daniela Schlatzer; Shenghan Lai; Jag H Khalsa; Raul N Mandler; Richard L Ehman; Marianna K Baum
Journal:  Drug Alcohol Depend       Date:  2022-01-12       Impact factor: 4.852

4.  S-Glutathionylation and Redox Protein Signaling in Drug Addiction.

Authors:  Jacqueline S Womersley; Joachim D Uys
Journal:  Prog Mol Biol Transl Sci       Date:  2015-10-31       Impact factor: 3.622

5.  Lung glutathione adaptive responses to cigarette smoke exposure.

Authors:  Neal S Gould; Elysia Min; Steve Gauthier; Richard J Martin; Brian J Day
Journal:  Respir Res       Date:  2011-10-07

6.  Effects of Glutathione on Growth, Intestinal Antioxidant Capacity, Histology, Gene Expression, and Microbiota of Juvenile Triploid Oncorhynchus mykiss.

Authors:  Chang'an Wang; Baohui Su; Shaoxia Lu; Shicheng Han; Haibo Jiang; Zhuang Li; Yang Liu; Hongbai Liu; Yuhong Yang
Journal:  Front Physiol       Date:  2021-11-29       Impact factor: 4.566

7.  The Role of Acetyl Cysteine in Cocaethylene (Non-Acetaminophen) Acute Liver Failure.

Authors:  Getaw Worku Hassen; Amaninder Dhaliwal; Catherine Ann Jenninigs; Hossein Kalantari
Journal:  Case Rep Emerg Med       Date:  2018-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.